Skip to main content

Table 1 Demographics, clinical parameters, and laboratory findings of the cohort

From: Intravoxel incoherent motion diffusion-weighted imaging for predicting kidney allograft function decline: comparison with clinical parameters

Characteristics

Results

Age (years)a

38 ± 10

Sex (male) (n, %)

69 (71.13)

Baseline serum creatinine (mg/dL)b

1.53 (1.15–2.18)

Baseline eGFR (mL/min/1.73 m2)b

56 (35–77.5)

Proteinuria (g/24 h)b

0.39 (0.30–0.80)

Hemoglobin (g/dL)a

12.1 ± 2.5

Hematocrita

0.369 ± 0.069

Albumin (g/L)a

43.3 ± 5.7

Immunosuppressive regimen

Prednisone + mycophenolic acid + tacrolimus (n, %)

78 (80.41)

Prednisone + mycophenolic acid + cyclosporine A (n, %)

6 (6.19)

Others (n, %)

13 (13.40)

Causes for end-stage kidney disease

Unknown (n, %)

80 (82.47)

Glomerulonephritides (n, %)

13 (13.40)

Other (n, %)

4 (4.13)

Follow-up time (months)b

98 (44–103)

  1. aIndicated data are presented with mean ± standard deviation, whereas b denoted data expression as median with interquartile range